Vimarsana
Biggest News Aggregation in the World

Jun Zhong News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jun Zhong. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jun Zhong Today - Breaking & Trending Today

Everything Evanston: Behind the boba in downtown Evanston - Vimarsana News

Everything Evanston: Behind the boba in downtown Evanston

Explore some of Evanston’s boba shops on today’s episode of Everything Evanston. [nat sound: entering boba shop] SHAE LAKE: In a college town, it’s not unusual to see a bright, bubbly storefront where students love to gather to get bubble tea. In downtown Evanston, there are at least seven. We’re going to explore a few...

Applied Pharmaceutical Science Inc. Announces FDA Approval of Investigational New Drug Application for APS03118, a Next generation RET Original New Drug for Unlimited Cancers - Vimarsana News

Applied Pharmaceutical Science Inc. Announces FDA Approval of Investigational New Drug Application for APS03118, a Next generation RET Original New Drug for Unlimited Cancers

/PRNewswire/ -- Applied Pharmaceutical Science, Inc. ("APS" or "the Company"), has recently announced the Investigational New Drug (IND) application for its...

Applied Pharmaceutical Science Inc. Announces FDA Approval of Investigational New Drug Application for APS03118, a Next generation RET Original New Drug for Unlimited Cancers - Vimarsana News

Applied Pharmaceutical Science Inc. Announces FDA Approval of Investigational New Drug Application for APS03118, a Next generation RET Original New Drug for Unlimited Cancers

/PRNewswire/ -- Applied Pharmaceutical Science, Inc. ("APS" or "the Company"), has recently announced the Investigational New Drug (IND) application for its...

Applied Pharmaceutical Science, Inc.: Applied Pharmaceutical Science Inc. Announces FDA Approval of Investigational New Drug Application for APS03118, a Next generation RET Original New Drug for Unlimited Cancers - Vimarsana News

Applied Pharmaceutical Science, Inc.: Applied Pharmaceutical Science Inc. Announces FDA Approval of Investigational New Drug Application for APS03118, a Next generation RET Original New Drug for Unlimited Cancers

BEIJING and PHILADELPHIA, Jan. 24, 2022 /PRNewswire/ -- Applied Pharmaceutical Science, Inc. ("APS" or "the Company"), has recently announced the Investigational New Drug (IND) application for

FDA approves Applied Pharmaceutical's IND application for APS03118 - Vimarsana News

FDA approves Applied Pharmaceutical's IND application for APS03118

The US FDA has approved IND application for Applied Pharmaceutical Science’s RET original new drug, APS03118, to treat unlimited cancer types.